Lifestyle
- Regular aerobic exercise
- Adequate hydration
- Avoiding excessive alcohol consumption
Mean Corpuscular Hemoglobin · Mittleres Hämoglobin pro Erythrozyt
MCH measures the average amount of hemoglobin per red blood cell.
Reference ranges may vary slightly based on laboratory standards.
Mean Corpuscular Hemoglobin (MCH) is a blood biomarker that quantifies the average amount of hemoglobin per red blood cell. Hemoglobin is a protein in red blood cells responsible for oxygen transport throughout the body. MCH is calculated by dividing the total hemoglobin by the red blood cell count, providing insight into the oxygen-carrying capacity of the blood. Clinically, MCH is a critical parameter in the complete blood count (CBC) used to diagnose and monitor anemia and other hematologic disorders. Researchers have found that low MCH values are indicative of microcytic hypochromic anemia, often seen in conditions like iron deficiency anemia and thalassemia. Elevated MCH values may suggest macrocytic anemia, which can occur in vitamin B12 or folate deficiencies. In the context of athletic performance and biohacking, maintaining optimal MCH levels is crucial for ensuring efficient oxygen delivery to tissues, which can enhance endurance and recovery. However, researchers observed that MCH values can be influenced by factors such as hydration status, recent blood loss, or underlying chronic diseases, which should be considered when interpreting results. Time-of-day and fasting do not significantly affect MCH levels, but it is important to account for potential confounders such as recent intense exercise or acute illness.
Klinische Bedeutung
Reduced MCH values indicate microcytic hypochromic anemia, common in iron deficiency and thalassemia. Elevated MCH values suggest macrocytic anemia, often due to vitamin B12 or folate deficiency.
Progressively rising MCH values may indicate macrocytic anemia. Re-test in 4 weeks if values are outside the optimal range.
Progressively falling MCH values may suggest developing microcytic anemia.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a physician before starting supplementation, especially with iron, to avoid toxicity.
Testing Frequency
Annually as part of a complete blood count for healthy adults.
May affect
Current research suggests that reference ranges for mean corpuscular hemoglobin (MCH) may vary significantly across different populations, particularly in pediatric cohorts, indicating a need for age- and sex-specific standards. Researchers have not yet established optimal MCH targets for differentiating between thalassemia carriers and those with iron deficiency anemia. Additionally, clinical questions remain unanswered regarding the impact of genetic variations on MCH levels and their role in the diagnosis of hemoglobinopathies.
427
Total Citations
10
Human/RCT
2.6
Avg. Influence
2025
Latest
This study examined the laboratory diagnosis of thalassemia, highlighting that carriers present with low mean corpuscular hemoglobin (MCH) levels. Researchers found that β-thalassemia carriers have significantly reduced MCH values (19-23 pg), and HbA2 determination is crucial for detection. Molecular analysis is essential for confirming α-thalassemia carrier status.
This guideline discusses the laboratory diagnosis of hemoglobinopathies, emphasizing the role of MCH in identifying carriers of thalassemias. Researchers found that testing for β-thalassemia trait is recommended when MCH is below 27 pg. The study also highlights the importance of genetic counseling.
This study addressed the handling of lipemic samples in clinical laboratories, noting that lipemia can interfere with laboratory results. Researchers highlighted the importance of monitoring mean corpuscular hemoglobin concentration (MCHC) in lipemic samples to ensure accurate measurements. The study calls for standardized protocols for managing such interferences.
Researchers investigated the association between mean corpuscular hemoglobin concentration (MCHC) and prognosis in patients with COPD exacerbation. The study found that lower MCHC was linked to higher 30-day mortality rates, suggesting it may serve as a valuable prognostic biomarker.
Researchers compared methods for targeted single-cell proteomics, focusing on hemoglobin quantification in erythrocytes. The study found that MCH levels in isolated red blood cells were comparable to reference ranges, indicating the effectiveness of the CellenONE device for single-cell analysis.
Researchers established age- and sex-specific reference intervals for hematologic parameters in healthy children and adolescents. The study found that most parameters, including mean corpuscular hemoglobin, showed significant changes during growth. This pediatric reference database will aid in more accurate test result interpretation.
This narrative review examined the effects of oral contraceptives on hematological profiles. Researchers found that oral contraceptive users typically had higher hemoglobin and erythrocyte counts, while mean corpuscular hemoglobin metrics did not significantly change. The review suggests further studies for pooled effects.
This study investigated the safety of lincomycin and spectinomycin hydrochloride injections in chickens. Researchers found that a dose of 20 mg/kg body weight had no adverse effects on growth performance or clinical blood parameters.
Researchers explored the diagnosis of hereditary spherocytosis (HS) and found that traditional erythrocyte parameters, including mean corpuscular hemoglobin (MCH), are essential for diagnosis. They noted advancements in diagnostic methods, including new parameters from blood cell counters. The study emphasizes the importance of combining clinical evaluations with laboratory data for accurate diagnosis.
This literature review addressed unresolved laboratory issues in identifying β-thalassemia carriers. Researchers found that combining mean corpuscular volume and mean corpuscular hemoglobin (MCH) with hemoglobin analysis improves diagnostic accuracy, despite challenges from genetic factors.
Research publications about MCH over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer